Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About MS Interactive Breakdown Better Bets vs. MS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Morgan Stanley (MS)

Market Price (10/31/2025): $164.25 | Market Cap: $259.0 Bil
Sector: Financials | Industry: Investment Banking & Brokerage

Morgan Stanley (MS)

Market Price (10/31/2025): $164.25
Market Cap: $259.0 Bil
Sector: Financials
Industry: Investment Banking & Brokerage

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.7%		 Trading close to highs
Dist 52W High is -0.5%, Dist 3Y High is -0.5%		 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 93%
1 Low stock price volatility
Vol 12M is 33%		 Moderate capital ratio
Tier 1 Capital / Risk Wtd Assets RatioTier 1 Capital / Risk-Weighted Assets is a common measure of financial strength for a bank. It reflects how much equity there is relative to assets where assets are weighted based on riskiness. Low ratios indicate the bank is highly vulnerable to even small changes in the value of their risk assets. is 9.5%		 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -29%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -34%
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.7%
1 Low stock price volatility
Vol 12M is 33%
2 Trading close to highs
Dist 52W High is -0.5%, Dist 3Y High is -0.5%
3 Moderate capital ratio
Tier 1 Capital / Risk Wtd Assets RatioTier 1 Capital / Risk-Weighted Assets is a common measure of financial strength for a bank. It reflects how much equity there is relative to assets where assets are weighted based on riskiness. Low ratios indicate the bank is highly vulnerable to even small changes in the value of their risk assets. is 9.5%
4 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 93%
5 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -29%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -34%

Market Valuation & Key Metrics

MSS&P 500
REVENUE GROWTHFAIR
Rev LTM ($ Bil)61.5
Rev Chg Q11.3%6.4%
Rev Chg LTM16.7%5.4%
Rev Chg 3Y Avg5.0%5.3%
PROFITABILITYGOOD
Op Inc LTM ($ Bil)�
CFO LTM ($ Bil)-17.7
Net Inc LTM ($ Bil)14.8
CFO/Rev LTM-28.7%20.4%
Net Inc Mgn24.0%12.8%
VALUATIONMODERATE
P/S4.23.2
P/CFO-14.715.5
P/FCF-12.420.6
P/E17.623.6

MS Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 42.5% change in MS stock from 5/1/2025 to 10/30/2025 was primarily driven by a 28.9% change in the company's P/E Multiple.

501202510302025Change
Stock Price ($)115.95165.2642.52%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)57621.0061503.006.74%
Net Income Margin (%)23.24%23.99%3.25%
P/E Multiple13.7017.6628.92%
Shares Outstanding (Mil)1582.001577.000.32%
Cumulative Contribution42.52%

LTM = Last Twelve Months as of date shown
The 44.3% change in MS stock from 10/30/2024 to 10/30/2025 was primarily driven by a 21.4% change in the company's Net Income Margin (%).

1030202410302025Change
Stock Price ($)114.50165.2644.33%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)52688.0061503.0016.73%
Net Income Margin (%)19.76%23.99%21.40%
P/E Multiple17.5317.660.76%
Shares Outstanding (Mil)1594.001577.001.07%
Cumulative Contribution44.31%

LTM = Last Twelve Months as of date shown
The 121.2% change in MS stock from 10/31/2022 to 10/30/2025 was primarily driven by a 88.2% change in the company's P/E Multiple.

1031202210302025Change
Stock Price ($)74.70165.26121.24%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)53814.0061503.0014.29%
Net Income Margin (%)25.21%23.99%-4.81%
P/E Multiple9.3817.6688.21%
Shares Outstanding (Mil)1704.001577.007.45%
Cumulative Contribution120.01%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
MS Return38%47%-10%14%40%34%285%
Peers Return2%31%-15%17%57%39%194%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
MS Win Rate75%75%50%50%58%67% 
Peers Win Rate55%60%42%50%68%69% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
MS Max Drawdown-45%-2%-25%-15%-10%-20% 
Peers Max Drawdown-42%-2%-31%-11%-2%-17% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: JPM, BAC, GS, C, IBKR. See MS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventMSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-33.0%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven49.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven845 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-51.6%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven106.8%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven238 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-37.2%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven59.2%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven700 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-87.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven704.0%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven4431 days1480 days

Compare to JPM, BAC, GS, C, IBKR


In The Past

Morgan Stanley's stock fell -33.0% during the 2022 Inflation Shock from a high on 2/9/2022. A -33.0% loss requires a 49.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Morgan Stanley (MS)

Interactive Breakdown

Morgan Stanley Interactive Breakdown Analysis

Better Bets than Morgan Stanley (MS)

 MSBetter Performance than MS
MetricValueIndustry (Investment Banking & Brokerage)
Rev Chg LTM16.7%SCHW (16.9%), HLI (23.3%), EVR (23.4%), MC (42.9%), BGC (21.7%)
Rev Chg 3Y Avg5.0%SCHW (5.0%), RJF (8.3%), IBKR (53.4%), MC (6.0%), BGC (11.1%)
CFO/Rev LTM-28.7%SCHW (82.3%), RJF (15.8%), IBKR (157.8%), HLI (31.5%), SF (20.1%)
FCF/Rev LTM-34.0%SCHW (79.4%), RJF (14.4%), IBKR (157.2%), HLI (29.8%), SF (18.9%)
Total Yield5.7%GS (6.3%), RJF (6.7%), SF (6.7%), PIPR (5.9%), MC (8.1%)
 MSBetter Performance than MS
MetricValueAll Other Sectors
Rev Chg LTM16.7%NVDA (71.6%), AVGO (28.0%), META (21.3%), LLY (36.8%), PLTR (38.8%)
Rev Chg 3Y Avg5.0%NVDA (92.0%), MSFT (13.2%), GOOGL (11.0%), AMZN (11.3%), AVGO (24.0%)
CFO/Rev LTM-28.7%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM-34.0%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield5.7%XOM (9.7%), JNJ (8.2%), BABA (36.3%), HD (6.3%), UNH (8.1%)
 Best Bets In Financials Sector
 MSDBRG OTF MTG NMIH CACC ENVA FNF ACGL APAM FI
What You Pay           
P/E17.739.713.28.47.512.310.213.98.610.510.6
P/EBIT�64.79.06.45.59.97.88.97.66.15.8
What You Get           
Rev Chg Q11.3%-102.4%1,228.5%-0.7%7.2%8.3%16.3%16.8%22.4%4.4%8.0%
Rev Chg LTM16.7%-84.8%89.0%2.2%10.0%12.5%21.1%7.4%23.5%10.0%6.7%
Rev Chg 3Y Avg5.0%125.8%221.9%1.2%10.1%6.9%23.5%-0.7%29.8%0.2%7.5%
FCF/Rev 3Y Avg-47.4%101.2%76.2%62.2%58.8%57.1%54.7%50.8%38.4%29.0%20.7%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1How Low Can Morgan Stanley Stock Really Go?Return 
2MS Dip Buy Analysis  
3Day 11 of Gains Streak for Morgan Stanley Stock with 10% Return (vs. 16% YTD) [7/7/2025]  
4Day 9 of Gains Streak for Morgan Stanley Stock with 8.4% Return (vs. 14% YTD) [7/1/2025]  
5Day 9 of Gains Streak for Morgan Stanley Stock with 8.4% Return (vs. 14% YTD) [7/1/2025]  
6Day 8 of Gains Streak for Morgan Stanley Stock with 8.3% Return (vs. 14% YTD) [6/30/2025]  
7Day 8 of Gains Streak for Morgan Stanley Stock with 8.3% Return (vs. 14% YTD) [6/30/2025]  
8Day 7 of Gains Streak for Morgan Stanley Stock with 8.1% Return (vs. 14% YTD) [6/27/2025]  
9Day 6 of Gains Streak for Morgan Stanley Stock with 7.4% Return (vs. 13% YTD) [6/26/2025]  
10MS YTD Stock Return Of 4.3% Outperforms BAC by 3.0% and Underperforms IBKR by -16%Return 
11ARTICLES  
12Buy Morgan Stanley Stock Ahead Of Earnings? October 10th, 2025
13Large Cap Stocks Trading At 52-Week High September 4th, 2025
14S&P 500 Stocks Trading At 52-Week High August 26th, 2025
15MS Stock Up 10% after 11-Day Win Streak July 8th, 2025
16MS Stock Up 8.1% after 7-Day Win Streak June 30th, 2025
Title
0DASHBOARDS
1Buy Morgan Stanley Stock Ahead Of Earnings?
2Large Cap Stocks Trading At 52-Week High
3S&P 500 Stocks Trading At 52-Week High
4MS Stock Up 10% after 11-Day Win Streak
5MS Stock Up 8.1% after 7-Day Win Streak
6ARTICLES
7How Low Can Morgan Stanley Stock Really Go?
8MS Dip Buy Analysis
9Day 11 of Gains Streak for Morgan Stanley Stock with 10% Return (vs. 16% YTD) [7/7/2025]
10Day 9 of Gains Streak for Morgan Stanley Stock with 8.4% Return (vs. 14% YTD) [7/1/2025]
11Day 9 of Gains Streak for Morgan Stanley Stock with 8.4% Return (vs. 14% YTD) [7/1/2025]
12Day 8 of Gains Streak for Morgan Stanley Stock with 8.3% Return (vs. 14% YTD) [6/30/2025]
13Day 8 of Gains Streak for Morgan Stanley Stock with 8.3% Return (vs. 14% YTD) [6/30/2025]
14Day 7 of Gains Streak for Morgan Stanley Stock with 8.1% Return (vs. 14% YTD) [6/27/2025]
15Day 6 of Gains Streak for Morgan Stanley Stock with 7.4% Return (vs. 13% YTD) [6/26/2025]
16MS YTD Stock Return Of 4.3% Outperforms BAC by 3.0% and Underperforms IBKR by -16%

Trade Ideas

Select past ideas related to MS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-14.4%-14.4%-14.4%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		0.3%0.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-7.7%-7.7%-7.7%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		15.0%15.0%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Morgan Stanley

Financials

MSJPMBACGSCIBKRMedian
NameMorgan S.JPMorgan.Bank of .Goldman .CitigroupInteract. 
Mkt Price165.26309.4453.03790.16100.2268.51132.74
Mkt Cap260.6862.9407.2247.9186.030.1254.2
Rev LTM61,503175,656103,43556,21383,1139,59572,308
Op Inc LTM-----8,0548,054
FCF LTM-20,941-148,6154,550-24,879-93,68615,087-22,910
FCF 3Y Avg-25,282-56,10424,365-27,212-65,6908,403-26,247
CFO LTM-17,670-148,6154,550-22,852-87,16515,143-20,261
CFO 3Y Avg-21,957-56,10424,365-24,836-59,1828,458-23,396

Growth & Margins

MSJPMBACGSCIBKRMedian
NameMorgan S.JPMorgan.Bank of .Goldman .CitigroupInteract. 
Rev Chg LTM16.7%8.2%5.4%12.2%6.3%11.2%9.7%
Rev Chg 3Y Avg5.0%13.5%5.0%3.8%4.3%53.4%5.0%
Rev Chg Q11.3%6.7%6.0%14.5%8.1%7.3%7.7%
QoQ Delta Rev Chg LTM2.6%1.6%1.5%3.4%2.0%1.8%1.9%
Op Mgn LTM-----83.9%83.9%
Op Mgn 3Y Avg-----83.3%83.3%
QoQ Delta Op Mgn LTM------0.0%-0.0%
CFO/Rev LTM-28.7%-84.6%4.4%-40.7%-104.9%157.8%-34.7%
CFO/Rev 3Y Avg-41.3%-32.5%24.8%-46.4%-74.6%97.3%-36.9%
FCF/Rev LTM-34.0%-84.6%4.4%-44.3%-112.7%157.2%-39.2%
FCF/Rev 3Y Avg-47.4%-32.5%24.8%-51.2%-82.8%96.6%-40.0%

Valuation

MSJPMBACGSCIBKRMedian
NameMorgan S.JPMorgan.Bank of .Goldman .CitigroupInteract. 
Mkt Cap260.6862.9407.2247.9186.030.1254.2
P/S4.24.93.94.42.23.14.1
P/EBIT-----3.73.7
P/E17.715.314.615.913.135.915.6
P/CFO-14.7-5.889.5-10.8-2.12.0-4.0
Total Yield5.7%6.6%6.8%6.3%7.6%3.2%6.4%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.4%0.0%
FCF Yield 3Y Avg-16.0%-7.4%8.7%-14.8%-56.0%51.2%-11.1%
D/E1.40.60.81.52.00.01.1
Net D/E0.9-0.5-0.80.8-1.0-0.2-0.3

Returns

MSJPMBACGSCIBKRMedian
NameMorgan S.JPMorgan.Bank of .Goldman .CitigroupInteract. 
1M Rtn4.0%-1.9%2.8%-0.8%-1.3%-0.4%-0.6%
3M Rtn16.0%5.0%12.8%9.8%7.0%4.6%8.4%
6M Rtn42.5%26.6%33.5%44.2%49.2%57.6%43.3%
12M Rtn44.3%40.8%28.3%53.8%60.2%78.6%49.0%
3Y Rtn121.2%164.7%59.3%147.7%145.1%247.5%146.4%
1M Excs Rtn3.7%-2.1%3.0%-1.1%-0.1%-2.0%-0.6%
3M Excs Rtn9.4%-1.9%7.4%2.6%-0.2%-1.5%1.2%
6M Excs Rtn20.8%4.8%11.8%22.4%27.5%35.9%21.6%
12M Excs Rtn25.7%23.0%10.2%36.8%43.8%65.3%31.3%
3Y Excs Rtn51.2%94.8%-14.6%79.9%71.2%176.9%75.6%

FDIC Bank Data

Bank Loans

[valid:false, table:

FDIC Data As Of12312005
LOAN DETAILS 
All Real Estate Loans ($ Bil)0
Farm Loans ($ Bil)0
Commercial and Industrial Loans ($ Bil)2
Loans to Individuals (CC, revolving credit, auto, other) (non-mortgage) ($ Bil)0
Commercial Real Estate Loans not Secured by Real Estate ($ Bil)0
, map:[FDIC Data As Of:12312005, LOAN DETAILS:null, All Real Estate Loans ($ Bil):0.005362, Farm Loans ($ Bil):0.000000, Commercial and Industrial Loans ($ Bil):2.476197, Loans to Individuals (CC, revolving credit, auto, other) (non-mortgage) ($ Bil):0.000000, Commercial Real Estate Loans not Secured by Real Estate ($ Bil):0.000688]]

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/4/20255/5/20252/21/202511/4/20248/5/20245/3/20242/22/202411/3/20238/3/20235/2/20232/24/202311/3/2022
Key Financials Quarterly            
Total Revenue15,60416,51715,04314,33914,02414,21512,03112,41812,58213,63611,89812,139
Net Income3,5394,3153,7143,1883,0763,4121,5172,4082,1822,9802,2362,632
EPS2.152.622.251.911.852.040.861.391.251.721.281.49
Key Financials TTM            
Total Revenue TTM61,50359,92357,62154,60952,68851,24650,66750,53450,25549,92750,21052,025
Net Income TTM14,75614,29313,39011,19310,4139,5199,0879,80610,03010,34311,02912,489
Growth Rates Quarterly            
Total Revenue Growth11.3%16.2%25.0%15.5%11.5%4.2%1.1%2.3%2.7%-2.0%-13.2%-12.8%
Net Income Growth15.1%26.5%144.8%32.4%41.0%14.5%-32.2%-8.5%-12.5%-18.7%-39.5%-29.0%
Margins Quarterly            
Net Income Margin22.7%26.1%24.7%22.2%21.9%24.0%12.6%19.4%17.3%21.9%18.8%21.7%
Cash & Debt            
Total Cash109,30487,565100,08585,58982,30691,931146,774103,27095,452101,086177,04487,540
Total Debt352,338327,657310,421316,323292,337286,474276,387256,861256,267258,852246,216228,124
Net Debt / (Cash)243,034240,092210,336230,734210,031194,543129,613153,591160,815157,76669,172140,584
Cash Flows Quarterly            
FCF from Operations11,829-23,97611,800-17,3232,5254,360-17,7523,747-9,666-9,865-13,996-7,553
Cash Flows TTM            
FCF from Operations TTM-17,670-26,9741,362-28,190-7,120-19,311-33,536-29,780-41,080-16,501-6,3977,948
Returns to Shareholders Quarterly            
Dividends1,5841,6161,5851,5901,4671,4961,4771,5011,3791,4061,3781,405
Share Repurchases1,1292,0308528068231,7181,3421,5421,0892,2051,7452,608
Return on Invested Capital (ROIC) Quarterly            
ROIC5.9%7.3%7.1%5.6%5.9%7.1%4.8%6.3%5.5%7.7%13.1%7.6%
Return on Invested Capital (ROIC) TTM            
ROIC TTM6.1%6.0%6.4%4.9%5.0%5.0%7.1%6.5%6.3%6.7%16.2%9.0%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Wealth Management (WM)26,26824,41724,24319,08617,737
Institutional Securities (IS)23,06024,39329,83326,47620,386
Investment Management (IM)5,3705,3756,2203,7343,763
Intersegment Eliminations (I/E)-555-517-541-539-467
Total54,14353,66859,75548,75741,419


Net Income by Segment
$ Mil20242023202220212020
Wealth Management (WM)5,0225,1394,7343,3613,728
Institutional Securities (IS)3,4535,2428,9577,0124,599
Investment Management (IM)6396601,347615719
Intersegment Eliminations (I/E)-27-12-48-4
Total9,08711,02915,03410,9969,042


Assets by Segment
$ Mil20242023202220212020
Institutional Securities (IS)810,506  753,322691,201
Wealth Management (WM)365,168  355,595197,682
Investment Management (IM)18,019  6,9456,546
Total1,193,693  1,115,862895,429


Price Behavior

MS Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta1.241.371.371.231.351.20
Up Beta0.521.331.331.101.241.14
Down Beta0.881.181.081.421.451.34
Up Capture153%164%159%152%207%172%
Bmk +ve Days13233574144420
Stock +ve Days14284079141407
Down Capture127%121%136%112%115%103%
Bmk -ve Days8192952107330
Stock -ve Days7142447110343

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity15,098,399
Short Interest: % Change Since 93020253.6%
Average Daily Volume6,101,864
Days-to-Cover Short Interest2.47
Basic Shares Quantity1,577,000,000
Short % of Basic Shares1.0%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/15/20254.7%2.5% 
7/16/2025-1.3%-1.1%5.1%
4/11/20251.4%2.4%20.2%
1/16/20254.0%5.6%7.1%
10/16/20246.5%5.4%19.2%
7/16/20240.9%-2.7%-7.3%
1/16/2024-4.2%-4.4%-5.5%
10/18/2023-6.8%-10.9%0.4%
...
SUMMARY STATS   
# Positive151217
# Negative8116
Median Positive2.5%5.4%8.3%
Median Negative-2.0%-2.7%-5.5%
Max Positive6.6%9.6%21.4%
Max Negative-6.8%-10.9%-7.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025804202510-Q 6/30/2025
3312025505202510-Q 3/31/2025
12312024221202510-K 12/31/2024
93020241104202410-Q 9/30/2024
6302024805202410-Q 6/30/2024
3312024503202410-Q 3/31/2024
12312023222202410-K 12/31/2023
93020231103202310-Q 9/30/2023
6302023803202310-Q 6/30/2023
3312023502202310-Q 3/31/2023
12312022224202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022504202210-Q 3/31/2022
12312021224202210-K 12/31/2021
93020211103202110-Q 9/30/2021

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.